PharmaFluidics Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 27
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $670K
Latest Deal Amount
  • Investors
  • 11

PharmaFluidics General Information

Description

Developer of micro-chip-based chromatography columns designed to be used in biomarker, diagnostics and drug research and development applications. The company's columns help to identify substantially active compounds in complex biological samples, such as biopsies, proteome digests, culture media or bio-pharmaceutical actives, enabling researchers to rely on sensitive detection of a biomarker during analytical separation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Application Specific Semiconductors
Other Industries
Other Devices and Supplies
Biotechnology
Primary Office
  • Technologiepark-Zwijnaarde 82
  • 9052 Ghent
  • Belgium
+32 09 000 00 00

PharmaFluidics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaFluidics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 02-Jun-2020 $670K 000.00 Completed Generating Revenue
3. Later Stage VC 11-Jan-2018 00.00 000.00 000.00 Completed Generating Revenue
2. Later Stage VC 17-Jan-2017 $2.9M $3.58M 00.000 Completed Generating Revenue
1. Early Stage VC 30-Jun-2014 $680K $680K 00.000 Completed Generating Revenue
To view PharmaFluidics’s complete valuation and funding history, request access »

PharmaFluidics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C 000,000 000.00 000.00 00 000.00 00.00
Class B 00,000 000.0 000.0 00 000.0 0.000
Class B 250,262 $14.3 $14.3 1x $14.3 10.38%
Class B 116,500 $12.78 $12.78 1x $12.78 14.51%
To view PharmaFluidics’s complete cap table history, request access »

PharmaFluidics Executive Team (7)

Name Title Board Seat Contact Info
Paul Jacobs Ph.D Co-Founder and Chief Operating Officer
Johan Devenyns Ph.D Managing Director and Board Member
Joeri Denayer Ph.D Co-Founder and Scientific Advisor
Katrien Vanhonacker Vice President, Business Development and Sales
Bart Catrysse Vice President of Finance
You’re viewing 5 of 7 executive team members. Get the full list »

PharmaFluidics Board Members (12)

Name Representing Role Since
Annie Vereecken Self Board Member 000 0000
Danny Gonnissen Ph.D Qbic Fund Board Member 000 0000
Fasha Mahjoor Self Board Member 000 0000
Gert Desmet Ph.D PharmaFluidics Co-Founder, Board Member and Advisory Board Chairman 000 0000
Jeroen Bossche PMV Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

PharmaFluidics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaFluidics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
VLAIO Other 000 0000 000000 0
Federal Holding and Investment Company Holding Company Minority 000 0000 000000 0
HERAN Partners Venture Capital Minority 000 0000 000000 0
Rudi Marien Angel (individual) Minority 000 0000 000000 0
Theodorus Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »